Guggenheim Capital Has Boosted Mallinckrodt Pub LTD Co (MNK) Stake; Antares Pharma (ATRS) Had 4 Bullish Analysts

August 11, 2017 - By Vivian Park

Guggenheim Capital Llc increased Mallinckrodt Pub Ltd Co (MNK) stake by 84.02% reported in 2016Q4 SEC filing. Guggenheim Capital Llc acquired 409,263 shares as Mallinckrodt Pub Ltd Co (MNK)’s stock declined 25.01%. The Guggenheim Capital Llc holds 896,389 shares with $44.66 million value, up from 487,126 last quarter. Mallinckrodt Pub Ltd Co now has $3.55 billion valuation. The stock decreased 1.40% or $0.52 during the last trading session, reaching $36.52. About 2.14M shares traded. Mallinckrodt PLC (NYSE:MNK) has declined 30.39% since August 11, 2016 and is downtrending. It has underperformed by 47.09% the S&P500.

Among 4 analysts covering Antares Pharma (NASDAQ:ATRS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Antares Pharma had 5 analyst reports since March 9, 2016 according to SRatingsIntel. H.C. Wainwright initiated the stock with “Buy” rating in Friday, June 23 report. The rating was maintained by Jefferies on Monday, August 7 with “Buy”. Piper Jaffray maintained Antares Pharma Inc (NASDAQ:ATRS) on Tuesday, July 25 with “Buy” rating. The stock of Antares Pharma Inc (NASDAQ:ATRS) has “Buy” rating given on Wednesday, March 9 by Jefferies. See Antares Pharma Inc (NASDAQ:ATRS) latest ratings:

07/08/2017 Broker: Jefferies Rating: Buy New Target: $6.0000 Maintain
25/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $4.0000 Maintain
23/06/2017 Broker: H.C. Wainwright Rating: Buy New Target: $5.0000 Initiate
23/06/2017 Broker: Chardan Capital Markets Rating: Buy New Target: $5 Initiates Coverage On

Guggenheim Capital Llc decreased Commscope Hldg Co Inc (NASDAQ:COMM) stake by 40,564 shares to 29,912 valued at $1.11M in 2016Q4. It also reduced Archer Daniels Midland Co (NYSE:ADM) stake by 153,159 shares and now owns 1.51M shares. Universal Corp Va (NYSE:UVV) was reduced too.

Among 20 analysts covering Mallinckrodt (NYSE:MNK), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Mallinckrodt had 60 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Overweight” rating by Morgan Stanley on Thursday, December 3. As per Wednesday, August 24, the company rating was maintained by Piper Jaffray. On Wednesday, October 7 the stock rating was maintained by Deutsche Bank with “Buy”. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Overweight” rating by Barclays Capital on Thursday, September 24. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, August 4 report. Jefferies maintained it with “Buy” rating and $70 target in Tuesday, June 20 report. The stock of Mallinckrodt PLC (NYSE:MNK) has “Buy” rating given on Monday, April 24 by Jefferies. The company was initiated on Wednesday, June 29 by BMO Capital Markets. Jefferies maintained Mallinckrodt PLC (NYSE:MNK) rating on Wednesday, August 2. Jefferies has “Buy” rating and $7000 target. Northland Capital initiated Mallinckrodt PLC (NYSE:MNK) rating on Wednesday, October 14. Northland Capital has “Outperform” rating and $92 target.

Since February 14, 2017, it had 13 insider purchases, and 0 insider sales for $836,202 activity. The insider Hicks Michael-Bryant bought $14,602. Shares for $20,348 were bought by WATKINS IAN J. Fischer Meredith B bought $108,676 worth of stock or 2,000 shares. The insider LLOYD RONALD K. bought $206,320. On Friday, March 10 Harbaugh Matthew K bought $29,514 worth of Mallinckrodt PLC (NYSE:MNK) or 600 shares. $57,904 worth of Mallinckrodt PLC (NYSE:MNK) shares were bought by Lannum Coleman N III. Trudeau Mark also bought $50,466 worth of Mallinckrodt PLC (NYSE:MNK) on Tuesday, February 14.

Investors sentiment increased to 1.03 in Q4 2016. Its up 0.12, from 0.91 in 2016Q3. It improved, as 62 investors sold MNK shares while 130 reduced holdings. 70 funds opened positions while 127 raised stakes. 92.55 million shares or 0.45% more from 92.14 million shares in 2016Q3 were reported. Hong Kong-based Point72 Asia (Hong Kong) Limited has invested 0.12% in Mallinckrodt PLC (NYSE:MNK). Meiji Yasuda Life Insurance holds 4,780 shares. Dimensional Fund Advisors Ltd Partnership invested in 1.44 million shares. 10,000 were accumulated by New Jersey Better Educational Savings Trust. Gsa Prtnrs Llp stated it has 12,912 shares. Axa has invested 0% in Mallinckrodt PLC (NYSE:MNK). The United Kingdom-based Oxford Asset Management has invested 0.49% in Mallinckrodt PLC (NYSE:MNK). Bnp Paribas Arbitrage has 0.07% invested in Mallinckrodt PLC (NYSE:MNK). 4,376 were accumulated by Qs Invsts Limited Liability Company. 9,167 are owned by Gateway Advisers Ltd Llc. Ubs Asset Mngmt Americas has 0.07% invested in Mallinckrodt PLC (NYSE:MNK). Blackrock Ltd Liability Corp accumulated 771,849 shares. Cypress Cap Group invested in 10,803 shares. Senzar Asset Limited Liability Corporation owns 306,500 shares or 4.05% of their US portfolio. Convergence Inv Prtnrs Lc holds 0.04% or 5,605 shares.

Investors sentiment increased to 0.96 in 2016 Q4. Its up 0.14, from 0.82 in 2016Q3. It increased, as 6 investors sold Antares Pharma Inc shares while 20 reduced holdings. 9 funds opened positions while 16 raised stakes. 50.35 million shares or 0.38% less from 50.54 million shares in 2016Q3 were reported. Royal Financial Bank Of Canada invested in 0% or 9,750 shares. Kcg Incorporated accumulated 44,836 shares. Wells Fargo Communications Mn stated it has 631,000 shares. National Bank Of Mellon reported 0% in Antares Pharma Inc (NASDAQ:ATRS). Schwab Charles Invest Management holds 262,246 shares or 0% of its portfolio. Commonwealth Equity Service stated it has 45,630 shares. Colorado-based Janus Cap Mngmt Ltd Co has invested 0% in Antares Pharma Inc (NASDAQ:ATRS). Bnp Paribas Arbitrage Sa reported 29 shares. Morgan Stanley owns 393,279 shares. Jefferies Grp Limited Liability Corporation accumulated 170,000 shares. Janney Montgomery Scott Ltd Llc has 0% invested in Antares Pharma Inc (NASDAQ:ATRS). Tfs Capital Ltd Liability Co holds 0.02% or 26,516 shares in its portfolio. Fifth Third Bancorporation stated it has 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS). Stifel Financial Corp invested in 11,000 shares. Armistice Limited Liability Company holds 11.00M shares.

Since March 31, 2017, it had 1 insider buy, and 3 insider sales for $35,244 activity. Another trade for 30,000 shares valued at $87,276 was sold by GARRITY THOMAS J. 130,000 Antares Pharma Inc (NASDAQ:ATRS) shares with value of $363,272 were bought by Powell Fred M. On Tuesday, April 4 APPLE ROBERT F sold $120,070 worth of Antares Pharma Inc (NASDAQ:ATRS) or 40,000 shares. On Monday, April 3 JACOB LEONARD S sold $120,682 worth of Antares Pharma Inc (NASDAQ:ATRS) or 41,762 shares.

About 1.17 million shares traded or 9.35% up from the average. Antares Pharma Inc (NASDAQ:ATRS) has risen 207.14% since August 11, 2016 and is uptrending. It has outperformed by 190.44% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>